Read + Share
Yang M, Zhang J, Wei D, Yu T, et al. Inflammatory markers predict survival in patients with postoperative urothelial
carcinoma receiving tislelizumab (PD-1 inhibitor) adjuvant therapy. BMC Cancer 2024;24:196.
PMID: 38347460
|
 |
|
Yang M, Zhang J, Wei D, Yu T, et al. Inflammatory markers predict survival in patients with postoperative urothelial
carcinoma receiving tislelizumab (PD-1 inhibitor) adjuvant therapy. BMC Cancer 2024;24:196.
PMID: 38347460
|
|
|
|